Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening (Q82633620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

human papilloma virus

1 reference

human papillomavirus

29 September 2024

1

Tipaya Ekalaksananan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Chamsai Pientong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Supannee Sriamporn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Bunkerd Kongyingyoes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Prasit Pengsa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Pilaiwan Kleebkaow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Onanong Kritpetcharat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Max Parkin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

21 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

62-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

The epidemiology of human papillomavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Meta-analysis of Pap test accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Liquid-based cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Natural history of cervicovaginal papillomavirus infection in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Cervical cancer control, priorities and new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Risk Factors for Cervical Cancer in Thailand: a Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

Intermethod variation in detection of human papillomavirus DNA in cervical smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.01.033

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16494930%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference